PMA P150003S071
- Device
- SYNERGY MEGATRON Everolimus Eluting Platinum Chromium Coronary Stent System
- Applicant
- Boston Scientific Corporation
- PMA number
- P150003
- Supplement
- S071
- Product code
- NIQ
- Decision date
- 2021-03-19
- Generic name
- Coronary drug-eluting stent
- Approval order statement
- Approval of the protocol for the post-approval study (PAS) protocol.
Current openFDA PMA Record#
- Device
- SYNERGY MEGATRON Everolimus Eluting Platinum Chromium Coronary Stent System
- Applicant
- Boston Scientific Corporation
- PMA number
- P150003
- Supplement
- S071
- Product code
- NIQ
- Generic name
- Coronary drug-eluting stent
- Decision date
- 2021-03-19
- Decision code
- APPR
- Date received
- 2021-02-17
- Supplement type
- Normal 180 Day Track No User Fee
- Supplement reason
- Postapproval Study Protocol
- Approval order statement
- Approval of the protocol for the post-approval study (PAS) protocol.